Scholarlink

<p>Listeriolysin O (LLO) is a vital virulence factor for the intracellular replication and pathogenesis of <i>Listeria monocytogenes</i>. The search for an effective LLO activity inhibitor as an alternative approach for the treatment of <i>L. monocytogenes</i> infection has attracted great attention. Tanshinone IIA (Tan IIA) is a bioactive compound in the traditional Chinese medicine “Danshen”. In this study, the protective effect of Tan IIA against <i>L. monocytogenes</i> infection was investigated using hemolysis test, LDH release method, oligomerization assay and molecular dynamics simulation in combination with in vivo mouse experiment. Tan IIA significantly inhibited the pore-forming activity of LLO by forming a stable LLO − Tan IIA complex. Meanwhile, Tan IIA concentration-dependently decreased the cytotoxicity of <i>L. monocytogenes</i> toward J774 and BeWo cells with the inhibitory rates being 41.3% and 54.5% at concentration of 8&#xa0;µg/mL, respectively. Furthermore, the intracellular growth of <i>L. monocytogenes</i> was also inhibited by Tan IIA in an LLO-dependent manner. Of note, Tan IIA (80&#xa0;mg/kg) protected mice against <i>L. monocytogenes</i> infections with the increased survival rate of 26.7%, reduced bacterial loads, alleviated tissue damages, and diminished inflammation. In conclusion, Tan IIA might be a promising anti-virulence candidate for the treatment of L. <i>monocytogenes</i> infection.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Protective effect of tanshinone IIA against Listeria monocytogenes infection in vitro and in vivo

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月15日

查看全文
  • Haiting Wang,
  • Sangyu Hu,
  • Haihua Feng,
  • Hongxiang Sun

摘要

Listeriolysin O (LLO) is a vital virulence factor for the intracellular replication and pathogenesis of Listeria monocytogenes. The search for an effective LLO activity inhibitor as an alternative approach for the treatment of L. monocytogenes infection has attracted great attention. Tanshinone IIA (Tan IIA) is a bioactive compound in the traditional Chinese medicine “Danshen”. In this study, the protective effect of Tan IIA against L. monocytogenes infection was investigated using hemolysis test, LDH release method, oligomerization assay and molecular dynamics simulation in combination with in vivo mouse experiment. Tan IIA significantly inhibited the pore-forming activity of LLO by forming a stable LLO − Tan IIA complex. Meanwhile, Tan IIA concentration-dependently decreased the cytotoxicity of L. monocytogenes toward J774 and BeWo cells with the inhibitory rates being 41.3% and 54.5% at concentration of 8 µg/mL, respectively. Furthermore, the intracellular growth of L. monocytogenes was also inhibited by Tan IIA in an LLO-dependent manner. Of note, Tan IIA (80 mg/kg) protected mice against L. monocytogenes infections with the increased survival rate of 26.7%, reduced bacterial loads, alleviated tissue damages, and diminished inflammation. In conclusion, Tan IIA might be a promising anti-virulence candidate for the treatment of L. monocytogenes infection.